Global Health News and Research

RSS

Researchers track down two new relatives of rubella virus

At night in a Ugandan forest, a team of American and African scientists take oral swabs from insect-eating cyclops leaf-nosed bats.

8 Oct 2020

Experimental Chinese SARS-CoV-2 vaccine appears safe in early trials

A new study published on the preprint server medRxiv in October 2020 reports the findings of a phase I trial of an inactivated SARS-CoV-2 vaccine, demonstrating that it can elicit a potent immune response without significant adverse reactions.

7 Oct 2020

Plasma ABO protein is a causal risk factor for severe COVID-19

Researchers used an integrative genomics approach to find the genes responsible for COVID-19 and its severity.

7 Oct 2020

Does the federal health information privacy law protect President Trump?

Within one day, President Donald Trump announced his COVID diagnosis and was admitted to Walter Reed National Military Medical Center for treatment.

7 Oct 2020

Native freshwater bacteria can destroy toxins produced during harmful algal blooms

Searching for new ways to address the growing threat to drinking water in northwest Ohio and across the globe, Dr. Jason Huntley discovered that native freshwater bacteria can destroy toxins produced during harmful algal blooms.

7 Oct 2020

Most Australians favourable to a COVID-19 vaccination

Now, a new study published on the preprint server medRxiv* by scientists at the University of New South Wales aimed to determine the public perfections regarding a future COVID-19 vaccine in Australia. They wanted to know if Australians would get the vaccine if one becomes available.

5 Oct 2020

800 million children have high lead levels in their blood

As many as 800 million children have dangerously high lead values in their blood. The neurotoxin can cause permanent brain damage.

1 Oct 2020

PATH wins grant to develop oral treatment option for soil-transmitted helminth infections

PATH announced today they received a grant from Japan's Global Health Innovative Technology Fund to develop a new oral treatment option for soil-transmitted helminth infections.

1 Oct 2020

Tufts University to lead $100 million program to address threats posed by zoonotic viral diseases

Tufts University will lead a $100 million, five-year program to understand and address threats posed by zoonotic viral diseases that can "spill over" from animals to humans, such as SARS-CoV-2, in an effort to reduce risk of infection, amplification, and spread, the United States Agency for International Development announced today.

30 Sep 2020

Health care spending in the U.S. could be attributed to modifiable risk factors

Modifiable health risks, such as obesity, high blood pressure, and smoking, were linked to over $730 billion in health care spending in the US in 2016, according to a study published in The Lancet Public Health.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

COVID-19 has created a perfect storm for people with heart disease

The COVID-19 pandemic is creating a perfect storm for heart health, the World Heart Federation warns on World Heart Day.

30 Sep 2020

Australian scientists develop a nasal spray that could stop SARS-CoV-2 infection

The novel product, called INNA-051, is being developed by Ena Respiratory, and laboratory experiments have shown that it reduced viral replication by as much as 96 percent in the animal study. Spearheaded by Public Health England’s (PHE) Deputy Director, Professor Miles Carroll, the new study described the potential treatment and has been published in the open-source preprint server bioRxiv*.

29 Sep 2020

Case fatality rates for COVID-19 and health indicators

Researchers from Turkey and Switzerland collaborated to study the nation-specific case fatality rates for COVID-19 caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The pandemic has affected around 33.5 million people worldwide and killed over 1 million making it one of the largest global health crises in recent memory.

29 Sep 2020

Dartmouth TB vaccine moves one step closer to a full Phase 3 efficacy trial

Results from the Phase 2 trial of the DAR-901 tuberculosis (TB) vaccine were announced today by investigators at Dartmouth's Geisel School of Medicine and published in the journal Vaccine.

29 Sep 2020

Corralling the facts on herd immunity

For a term that's at least 100 years old, "herd immunity" has gained new life in 2020.

29 Sep 2020

Fasting blood glucose levels upon admission tied to COVID-19 prognosis, study finds

In the study, which appeared on the pre-print open-source medRxiv* server, the investigators aimed to determine the prognostic value of blood glucose in predicting outcomes in COVID-19 disease, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

28 Sep 2020